Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 16

1.

Intralesional methotrexate treatment for keratoacanthoma tumors: a retrospective study and review of the literature.

Annest NM, VanBeek MJ, Arpey CJ, Whitaker DC.

J Am Acad Dermatol. 2007 Jun;56(6):989-93. Review.

PMID:
17504715
2.

Intralesional methotrexate for keratoacanthoma of the nose.

Cohen PR, Schulze KE, Teller CF, Nelson BR.

Skinmed. 2005 Nov-Dec;4(6):393-5.

PMID:
16276163
3.

Histopathology of cutaneous squamous cell carcinoma and its variants.

Kane CL, Keehn CA, Smithberger E, Glass LF.

Semin Cutan Med Surg. 2004 Mar;23(1):54-61. Review.

PMID:
15095916
4.

Methotrexate and psoriasis in the era of new biologic agents.

Saporito FC, Menter MA.

J Am Acad Dermatol. 2004 Feb;50(2):301-9. Review. No abstract available.

PMID:
14726893
5.

Identification of human papillomavirus in keratoacanthomas.

Forslund O, DeAngelis PM, Beigi M, Schjølberg AR, Clausen OP.

J Cutan Pathol. 2003 Aug;30(7):423-9.

PMID:
12859739
6.
7.

Nonmelanoma skin cancer.

Skidmore RA Jr, Flowers FP.

Med Clin North Am. 1998 Nov;82(6):1309-23, vi. Review.

PMID:
9889750
8.

Intralesional methotrexate in solitary keratoacanthoma.

Cuesta-Romero C, de Grado-Peña J.

Arch Dermatol. 1998 Apr;134(4):513-4. No abstract available.

PMID:
9580539
9.

Keratoacanthoma in Kauai, Hawaii. The first documented incidence in a defined population.

Chuang TY, Reizner GT, Elpern DJ, Stone JL, Farmer ER.

Arch Dermatol. 1993 Mar;129(3):317-9.

PMID:
8447667
10.

Keratoacanthoma.

Schwartz RA.

J Am Acad Dermatol. 1994 Jan;30(1):1-19; quiz 20-2. Review.

PMID:
8277007
11.

Solitary keratoacanthoma is a squamous-cell carcinoma: three examples with metastases.

Hodak E, Jones RE, Ackerman AB.

Am J Dermatopathol. 1993 Aug;15(4):332-42; discussion 343-52. Review. No abstract available.

PMID:
8214391
12.

Intralesional methotrexate in keratoacanthoma of the nose.

Hurst LN, Gan BS.

Br J Plast Surg. 1995 Jun;48(4):243-6.

PMID:
7640859
13.

Multiple keratoacanthomas.

Kopf AW.

Arch Dermatol. 1971 May;103(5):543-4. No abstract available.

PMID:
5580301
14.

Aggressive keratoacanthoma of the eyelid: "malignant" keratoacanthoma or squamous cell carcinoma?

Requena L, Romero E, Sánchez M, Ambrojo P, Sánchez Yus E.

J Dermatol Surg Oncol. 1990 Jun;16(6):564-8.

PMID:
2355136
15.

The pharmacology of methotrexate.

Olsen EA.

J Am Acad Dermatol. 1991 Aug;25(2 Pt 1):306-18. Review.

PMID:
1918470
16.

Treatment of keratoacanthomas with intralesional methotrexate.

Melton JL, Nelson BR, Stough DB, Brown MD, Swanson NA, Johnson TM.

J Am Acad Dermatol. 1991 Dec;25(6 Pt 1):1017-23.

PMID:
1810980

Supplemental Content

Support Center